Akavipat Phuping, Thinkhamrop Jadsada, Thinkhamrop Bandit, Sriraj Wimonrat
1Anesthesiology Department, Prasat Neurological Institute, Bangkok, Thailand; 2Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 3Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University, Khon Kaen, Thailand; 4Department of Anesthesiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Acta Clin Croat. 2019 Mar;58(1):50-56. doi: 10.20471/acc.2019.58.01.07.
The APACHE II scoring system is approved for its benchmarking and mortality predictions, but there are only a few articles published to demonstrate it in neurosurgical patients. Therefore, this study was performed to acknowledge this score and its predictive performance to hospital mortality in a tertiary referral neurosurgical intensive care unit (ICU). All patients admitted to the Neurosurgical ICU from February 1 to July 31, 2011 were recruited. The parameters indicated in APACHE II score were collected. The adjusted predicted risk of death was calculated and compared with the death rate observed. Descriptive statistics including the receiver operating characteristic curve (ROC) was performed. The results showed that 276 patients were admitted during the mentioned period. The APACHE II score was 16.56 (95% CI, 15.84-17.29) and 19.08 (95% CI, 15.40-22.76) in survivors and non-survivors, while the adjusted predicted death rates were 13.39% (95% CI, 11.83-14.95) and 17.49% (95% CI, 9.81-25.17), respectively. The observed mortality was only 4.35%. The area under the ROC of APACHE II score to the hospital mortality was 0.62 (95% CI, 0.44-0.79). In conclusion, not only the APACHE II score in neurosurgical patients indicated low severity, but its performance to predict hospital mortality was also inferior. Additional studies of predicting mortality among these critical patients should be undertaken.
急性生理与慢性健康状况评分系统(APACHE II)因其基准化和死亡率预测功能而得到认可,但仅有少数文章发表以证明其在神经外科患者中的应用。因此,本研究旨在了解该评分及其对三级转诊神经外科重症监护病房(ICU)患者医院死亡率的预测性能。招募了2011年2月1日至7月31日期间入住神经外科ICU的所有患者。收集了APACHE II评分中所涉及的参数。计算调整后的预测死亡风险,并与观察到的死亡率进行比较。进行了包括受试者工作特征曲线(ROC)在内的描述性统计。结果显示,在上述期间共收治了276例患者。幸存者和非幸存者的APACHE II评分分别为16.56(95%可信区间,15.84 - 17.29)和19.08(95%可信区间,15.40 - 22.76),而调整后的预测死亡率分别为13.39%(95%可信区间,11.83 - 14.95)和17.49%(95%可信区间,9.81 - 25.17)。观察到的死亡率仅为4.35%。APACHE II评分对医院死亡率的ROC曲线下面积为0.62(95%可信区间,0.44 - 0.79)。总之,神经外科患者的APACHE II评分不仅表明病情严重程度较低,而且其预测医院死亡率的性能也较差。应开展更多针对这些重症患者死亡率预测的研究。